Long-Term Effects of Sodium-Glucose Cotransporter Inhibitors on Refractory Hypomagnesemia and Urinary Magnesium Excretion.
Publication
, Journal Article
Shah, CV; Sparks, MA; Cassiman, D
Published in: Mayo Clin Proc
January 2026
Duke Scholars
Published In
Mayo Clin Proc
DOI
EISSN
1942-5546
Publication Date
January 2026
Volume
101
Issue
1
Start / End Page
199 / 200
Location
England
Related Subject Headings
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shah, C. V., Sparks, M. A., & Cassiman, D. (2026). Long-Term Effects of Sodium-Glucose Cotransporter Inhibitors on Refractory Hypomagnesemia and Urinary Magnesium Excretion. Mayo Clin Proc, 101(1), 199–200. https://doi.org/10.1016/j.mayocp.2025.09.003
Shah, Chintan V., Matthew A. Sparks, and David Cassiman. “Long-Term Effects of Sodium-Glucose Cotransporter Inhibitors on Refractory Hypomagnesemia and Urinary Magnesium Excretion.” Mayo Clin Proc 101, no. 1 (January 2026): 199–200. https://doi.org/10.1016/j.mayocp.2025.09.003.
Shah CV, Sparks MA, Cassiman D. Long-Term Effects of Sodium-Glucose Cotransporter Inhibitors on Refractory Hypomagnesemia and Urinary Magnesium Excretion. Mayo Clin Proc. 2026 Jan;101(1):199–200.
Shah, Chintan V., et al. “Long-Term Effects of Sodium-Glucose Cotransporter Inhibitors on Refractory Hypomagnesemia and Urinary Magnesium Excretion.” Mayo Clin Proc, vol. 101, no. 1, Jan. 2026, pp. 199–200. Pubmed, doi:10.1016/j.mayocp.2025.09.003.
Shah CV, Sparks MA, Cassiman D. Long-Term Effects of Sodium-Glucose Cotransporter Inhibitors on Refractory Hypomagnesemia and Urinary Magnesium Excretion. Mayo Clin Proc. 2026 Jan;101(1):199–200.
Published In
Mayo Clin Proc
DOI
EISSN
1942-5546
Publication Date
January 2026
Volume
101
Issue
1
Start / End Page
199 / 200
Location
England
Related Subject Headings
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences